<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="music/PMC4168724/results/search/funders/results.xml">
  <result pre="been a number of calls from groups such as the" exact="British Medical Association" post="(2007) 1 for more policy debate on enhancement technologies,"/>
  <result pre="some extent modifies neuronal connections. Further, the consensus amongst the" exact="European Commission," post="Member States and stakeholders is, reportedly, that having a"/>
  <result pre="purpose has been recognized. A working document published by the" exact="European Commission" post="during the recent consultation on the MDD explains: 40"/>
  <result pre="increasing production and use of these technologies. For example, the" exact="British Medical Association" post="published a report in 2007 on the ethical aspects"/>
  <result pre="in 2007 on the ethical aspects of cognitive enhancement; the" exact="European Commission" post="funded a 7th framework program on Ethics in Public"/>
  <result pre="Policy Making: The Case of Human Enhancement (EPOCH); 42 the" exact="Academy of Medical Sciences," post="in collaboration with the British Academy, the Royal Academy"/>
  <result pre="42 the Academy of Medical Sciences, in collaboration with the" exact="British Academy," post="the Royal Academy of Engineering and the Royal Society,"/>
  <result pre="of Medical Sciences, in collaboration with the British Academy, the" exact="Royal Academy of Engineering" post="and the Royal Society, published a report based on"/>
  <result pre="the British Academy, the Royal Academy of Engineering and the" exact="Royal Society," post="published a report based on their workshop investigating Human"/>
  <result pre="Outram and Racine (2011), 44 the report published by the" exact="British Medical Association" post="(BMA) 45 places emphasis on public debate in advance"/>
  <result pre="safety while supporting DIY innovation. To our knowledge, only the" exact="Nuffield Council on Bioethics" post="49 has outlined a model for the regulation of"/>
  <result pre="discussion of weighing the risks and benefits of CEDs). The" exact="European Commission," post="in its discussion of the policy options for extending"/>
  <result pre="make about their products. A guidance document published by the" exact="European Commission" post="elaborates on how this purpose is identified: 60 Medical"/>
  <result pre="side effects. It appears to be the view of the" exact="European Commission" post="that, as measurable benefits fall, less risk should be"/>
  <result pre="of the condition being diagnosed or treated implies that the" exact="European Commission" post="holds the view that the more severe the condition,"/>
  <result pre="of the risks tolerated will decrease. It seems that the" exact="European Commission" post="took such an approach when proposing the amendment for"/>
  <result pre="the remit of the MDD One concern raised by the" exact="European Commission" post="when discussing how to extend the MDD to cover"/>
  <result pre="drawn up. For the implantable and other invasive products, the" exact="European Commission" post="proposed to solve this by generating a positive list"/>
  <result pre="manufacturers In relation to implantable and other invasive products, the" exact="European Commission" post="also considered the implications for manufacturers, particularly of the"/>
  <result pre="supported by the Oxford Foundation on Ethics and Education and" exact="Wellcome Trust" post="(grant WT087211). Roi Cohen Kadosh was supported by the"/>
  <result pre="Trust (grant WT087211). Roi Cohen Kadosh was supported by the" exact="Wellcome Trust" post="(grant WT88378). Julian Savulescu was supported by the Uehiro"/>
  <result pre="supported by the Uehiro Foundation on Ethics and Education and" exact="Wellcome Trust" post="(grant WT086041) and Oxford Martin School. 1 British Medical"/>
  <result pre="and Wellcome Trust (grant WT086041) and Oxford Martin School. 1" exact="British Medical Association" post="Expert Group on Cognitive Enhancements, Boosting your brainpower: ethical"/>
  <result pre="Cognitive Enhancements, Boosting your brainpower: ethical aspects of cognitive enhancements," exact="British Medical Association" post="Discussion Paper (2007). 2 Hannah Maslen, Tom Douglas, Roi"/>
  <result pre="on the revision of the regulatory framework for medical devices," exact="European Commission" post="at 6. 41 Id. 42 See: http://epochproject.com/ (accessed 20"/>
  <result pre="2013). 43 Report from a Joint Workshop Hosted by The" exact="Academy of Medical Sciences," post="The British Academy, The Royal Academy of Engineering and"/>
  <result pre="Joint Workshop Hosted by The Academy of Medical Sciences, The" exact="British Academy," post="The Royal Academy of Engineering and The Royal Society"/>
  <result pre="by The Academy of Medical Sciences, The British Academy, The" exact="Royal Academy of Engineering" post="and The Royal Society (2012), Human Enhancement and the"/>
  <result pre="The British Academy, The Royal Academy of Engineering and The" exact="Royal Society" post="(2012), Human Enhancement and the Future of Work, The"/>
  <result pre="Society (2012), Human Enhancement and the Future of Work, The" exact="Academy of Medical Sciences." post="44 Simon M. Outram &amp;amp; Eric Racine, Examining Reports"/>
  <result pre="Accountability in Research: Policies and Quality Assurance 323â€“41 (2011). 45" exact="British Medical Association," post="supra note 1. 46 Id. at 1. 47 The"/>
  <result pre="Association, supra note 1. 46 Id. at 1. 47 The" exact="Academy of Medical Sciences," post="supra note 43, at 51. 48 Fitz and Reiner,"/>
  <result pre="at 51. 48 Fitz and Reiner, supra note 12. 49" exact="Nuffield Council on Bioethics" post="Report on Novel neurotechnologies: intervening in the brain (2013),"/>
  <result pre="Bioethics Report on Novel neurotechnologies: intervening in the brain (2013)," exact="Nuffield Council on Bioethics." post="50 Knechtel et al., supra note 10. 51 See,"/>
  <result pre="(2011). 53 Cohen Kadosh et al., supra note 23. 54" exact="British Medical Association," post="supra note 1, at 34. 55 Id. at 34."/>
  <result pre="The Oxford Handbook on Bioethics (B. Steinbock ed., 2006). 59" exact="European Commission," post="supra note 40, at 17. 60 European Commission's documents"/>
  <result pre="directive 93/42/EEC on medical devices (1994), Medical Devices: Guidance Document," exact="European Commission," post="p. 3, http://ec.europa.eu/health/medical-devices/files/meddev/2_1-1__04-1994_en.pdf 61 Note, however, that there is"/>
  <result pre="Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 (2012)," exact="European Commission," post="p. 101, http://ec.europa.eu/health/medical-devices/files/revision_docs/proposal_2012_542_en.pdf 63 European Commission's Document on Guidelines"/>
  <result pre="Clinical Evaluation: A Guide For Manufacturers And Notified Bodies (2009)," exact="European Commission," post="p. 16, http://ec.europa.eu/health/medical-devices/files/meddev/2_7_1rev_3_en.pdf. 64 European Commission, supra note 62,"/>
  <result pre="And Notified Bodies (2009), European Commission, p. 16, http://ec.europa.eu/health/medical-devices/files/meddev/2_7_1rev_3_en.pdf. 64" exact="European Commission," post="supra note 62, at 102. 65 MHRA's Document on"/>
  <result pre="Rawls, A Theory of Justice (1971, revised edition 1999). 71" exact="European Commission," post="supra note 40, at 11. 72 Id. at 15."/>
 </snippets>
</snippetsTree>
